Durable complete remission of therapy-refractory, tumor-stage cutaneous T-cell lymphoma under radioimmunotherapy with electron beam irradiation and denileukin diftitox.
Wobser
Marion
M
Göppner
Daniela
D
Lang
Sabrina C
SC
Beckmann
Gabriele
G
Flentje
Michael
M
Ugurel
Selma
S
Bröcker
Eva-B
EB
Becker
Jürgen C
JC
D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004167:Diphtheria Toxin / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D005528:Foot; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D016410:Lymphoma, T-Cell, Cutaneous / Q000175:diagnosis / Q000628:therapy*; D008297:Male; D009367:Neoplasm Staging; D018714:Radiotherapy, Adjuvant; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage / Q000627:therapeutic use; D012074:Remission Induction / Q000379:methods*; D012878:Skin Neoplasms / Q000175:diagnosis / Q000628:therapy*
D000970:Antineoplastic Agents; D004167:Diphtheria Toxin; D007376:Interleukin-2; D011993:Recombinant Fusion Proteins; C078456:denileukin diftitox